Whalesbook
Yaar, market mein na current situation badi tense chal rahi hai. Ek taraf toh FIIs (Foreign Institutional Investors) apna bearish bet badha rahe hain, matlab futures pe short kar rahe hain, aur dusri taraf kuch domestic sectors dum dikha rahe hain.
FIIs ne na Indian index futures pe itna short kiya hai ki unka long-short ratio 16.8 ho gaya hai. Ye number February end ke baad sabse high hai. Matlab ya toh market mein ekdum se sharp rally aayegi short covering ki wajah se, ya fir FIIs ko lagta hai ki market aur girega. April 2, 2026 ko toh FIIs ne NSE pe ₹9,229.52 crore aur overall ₹9,931.13 crore ka maal becha. Lekin achhi baat ye hai ki DIIs (Domestic Institutional Investors) ne support diya, NSE pe ₹6,709.74 crore aur overall ₹7,208.41 crore ki buying ki.
Market mein na sab jagah ek jaisa haal nahi hai. Small-cap indices mein phir se jaan aa gayi hai, unke 60% se zyada companies apni 10-day moving average ke upar trade kar rahi hain. Iska matlab risk lene ki capacity wapas aa rahi hai. Lekin Nifty Financial Services index ka haal kharab hai, yahan sirf 15% companies hi apni 10-day moving average ke upar hain. Banking sector toh April 2, 2026 ko khaas kar ke weak dikha.
Ab sectors ki baat karein toh Nifty Pharma index girne ke baad ab support ke paas hai, lag raha hai ki oversold ho gaya hai aur jaldi bounce kar sakta hai. Sun Pharmaceutical Industries jiska P/E lagbhag 37.2 hai aur Cipla jiska P/E 21.2 hai, woh potential reversal ke signals de rahe hain. Analysts toh Sun Pharma pe 'Buy' rating de rahe hain aur 14.60% tak ka rise expect kar rahe hain. Haan, April 1, 2026 ko pharma sector 0.99% gira tha, par ye usually weak market mein defensive sector rehta hai.
Aur Nifty Metal index ki baat karein toh woh ek strong uptrend mein consolidate kar raha hai. Prices key moving averages ke upar hain. MACD ka niche cross hona shayad bas ek pause hai, trend reversal nahi. Momentum indicators bhi normal ho rahe hain. March 4, 2026 ko bhi is sector ne thodi strength dikhai thi, shayad iske safe-haven appeal ki wajah se. Metals mein JSW Steel ka P/E 47.6, Tata Steel ka 28.1, aur Vedanta ka 24.5 hai, jo valuation differences dikha raha hai.
Risk ki baat karein toh, FIIs ke itne zyada short hone se short squeeze ho sakta hai, par risks bhi hain. Agar global problems jaise ki geopolitical tensions aur interest rate ki chinta badhti hai, toh FIIs ki selling DIIs ki buying pe bhaari pad sakti hai aur indices ko neeche dhakel sakti hai. Kuch companies ki valuations bhi high lag rahi hain, jaise JSW Steel (47.6 P/E) aur Sun Pharma (37.2 P/E). Adani Enterprises ka P/E alag alag reports mein vary karta hai (16.8 se 64.2), aur kai log 'other income' ke earnings quality pe asar ko lekar chintit hain. Financial services sector ki lagatar kamzori bhi credit ya liquidity issues ki taraf ishara kar sakti hai. Pharma sector ko bhi regulatory challenges face karne pad sakte hain.
Overall dekha jaye toh Indian stock market ki valuations ab thodi normalize ho rahi hain. Nifty forward earnings ke 17.5 times pe trade kar raha hai, jo uske long-term average se kam hai. Global risks hone ke bawajood, strong domestic buying market ko support kar rahi hai. Abhi jo FIIs ka record shorting aur sectors ka alag alag performance chal raha hai, usse lagta hai aage volatility badh sakti hai. Investors ko FII flows pe dhyan rakhna chahiye aur Pharma aur Metals indices ke key support levels ko monitor karna chahiye.